CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study

被引：9
|
作者：
Niu, Jiahua [1 ,2 ]
Qiu, Huiying [1 ,2 ]
Xiang, Fang [3 ]
Zhu, Lin [3 ]
Yang, Jun [1 ,2 ]
Huang, Chongmei [1 ,2 ]
Zhou, Kun [1 ,2 ]
Tong, Yin [1 ,2 ]
Cai, Yu [1 ,2 ]
Dong, Baoxia [1 ,2 ]
Lu, Yuan [3 ]
Sun, Xuedong [3 ]
Wan, Liping [1 ,2 ]
Ding, Xueying [2 ]
Wang, Haopeng [4 ]
Song, Xianmin [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Dept Hematol, Shanghai, Peoples R China
[2] Shanghai Sci & Technol Comm STCSM, Engn Technol Res Ctr Cell Therapy & Clin Translat, Shanghai, Peoples R China
[3] Hrain Biotechnol, Shanghai, Peoples R China
[4] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China
来源：
BLOOD CANCER JOURNAL | 2023年 / 13卷 / 01期
基金：
国家重点研发计划;
关键词：
THERAPY; CD19;
D O I：
10.1038/s41408-023-00813-x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphoma
    Tong, Chuan
    Zhang, Yajing
    Liu, Yang
    Ji, Xingyu
    Zhang, Wenying
    Guo, Yelei
    Han, Xiao
    Ti, Dongdong
    Dai, Hanren
    Wang, Chunmeng
    Yang, Qingming
    Liu, Wanli
    Wang, Yao
    Wu, Zhiqiang
    Han, Weidong
    BLOOD, 2020, 136 (14) : 1632 - 1644
  • [32] Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemia
    Dourthe, Marie-Emilie
    Rabian, Florence
    Yakouben, Karima
    Chevillon, Florian
    Cabannes-Hamy, Aurelie
    Mechinaud, Francoise
    Grain, Audrey
    Chaillou, Delphine
    Rahal, Ilhem
    Caillat-Zucman, Sophie
    Lesprit, Emmanuelle
    Naudin, Jerome
    Roupret-Serzec, Julie
    Parquet, Nathalie
    Brignier, Anne
    Guerin-El Khourouj, Valerie
    Lainey, Elodie
    Caye-Eude, Aurelie
    Cave, Helene
    Clappier, Emmanuelle
    Mathis, Stephanie
    Azoulay, Elie
    Dallel, Jean Hugues
    Dhedin, Nathalie
    Madelaine, Isabelle
    Larghero, Jerome
    Boissel, Nicolas
    Baruchel, Andre
    LEUKEMIA, 2021, 35 (12) : 3383 - 3393
  • [33] Perspectives of Fc engineered antibodies in CD19 targeting immunotherapies in pediatric B-cell precursor acute lymphoblastic leukemia
    Kellner, Christian
    Peipp, Matthias
    Gramatzki, Martin
    Schrappe, Martin
    Schewe, Denis M.
    ONCOIMMUNOLOGY, 2018, 7 (08):
  • [34] Donor-derived CD19 CAR-T Cells versus Chemotherapy Plus Donor Lymphocyte Infusion for Treatment of Recurrent CD19-positive B-ALL After Allogeneic Hematopoietic Stem Cell Transplantation
    Tan, Xu
    Wang, Xiao-qi
    Zhang, Cheng
    Zhao, Xian-lan
    Yao, Han
    Chen, Guo
    Ma, Ying-ying
    Wen, Qin
    Gao, Lei
    Gao, Li
    Kong, Pei-yan
    Shen, Yan
    Zhang, Xi
    Lou, Shi-feng
    CURRENT MEDICAL SCIENCE, 2023, 43 (04) : 733 - 740
  • [35] Preclinical evaluation of cyclophosphamide and fl udarabine combined with CD19 CAR-T in the treatment of B-cell hematologic malignancies in vivo
    Xia, Zhigang
    Tian, Mengyao
    Cheng, Yucai
    Yi, Wenfang
    Du, Zefan
    Li, Tianwen
    Wen, Yuchen
    Li, Lindi
    Liu, Yong
    Chen, Chun
    ONCOLOGY RESEARCH, 2024, 32 (06) : 1109 - 1118
  • [36] Neurotoxicity following CD19/CD28ζ CAR T-cells in children and young adults with B-cell malignancies
    Shalabi, Haneen
    Martin, Staci
    Yates, Bonnie
    Wolters, Pamela L.
    Kaplan, Claire
    Smith, Hannah
    Sesi, Christopher R.
    Jess, Jennifer
    Toledo-Tamula, Mary Ann
    Struemph, Kari
    Delbrook, Cindy P.
    Khan, Omar, I
    Mackall, Crystal L.
    Lee, Daniel W.
    Shah, Nirali N.
    NEURO-ONCOLOGY, 2022, 24 (09) : 1584 - 1597
  • [37] A CH2CH3 hinge region enhances the cytotoxicity of anti-CD5 CAR-T cells targeting T cell acute lymphoblastic leukemia
    Wu, Huantong
    Yu, Yajie
    Zhao, Yu
    Liu, Weihua
    Liu, Zhongfeng
    Zhang, Guangji
    Chen, Zhiguo
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 124
  • [38] Case report: The case of T-cell acute lymphoblastic leukemia treated with chemotherapy followed by anti-CD7 CAR-T cells using retroviral vector
    Zhou, Huanhuan
    Zhu, Wenxiang
    Ma, Qihong
    Liu, Ning
    Jin, Mengdi
    Feng, Yaru
    Zhao, Lijun
    Sun, Rui
    Li, Rongyou
    Li, Huaxiu
    Shi, Yuanyuan
    Wang, Jianxun
    Liu, Liqiong
    Guo, Zhi
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [39] Anti-CD79b/CD3 bispecific antibody combined with CAR19-T cells for B-cell lymphoma treatment
    Zheng, Wei-Wei
    Zhou, Hang
    Li, Ping
    Ye, Shi-Guang
    Abudureheman, Tuersunayi
    Yang, Li-Ting
    Qing, Kai
    Liang, Ai-Bin
    Chen, Kai-Ming
    Duan, Cai-Wen
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (11) : 3739 - 3753
  • [40] Enhanced cytotoxicity against solid tumors by bispecific antibody-armed CD19 CAR T cells: a proof-of-concept study
    Thakur, Archana
    Scholler, John
    Schalk, Dana L.
    June, Carl H.
    Lum, Lawrence G.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (08) : 2007 - 2016
12345